Trastuzumab ELISA Kit (DY286038)

Fiche technique Partager le produit Copier les informations

Aperçu
Images
Reférences
Fiche technique
SDS

Aperçu

Numéro de catalogue	DY286038
Description	Trastuzumab ELISA Kit (DY286038) — Quantitative sandwich ELISA for Trastuzumab. Sample: Plasma, Serum. Range: 78.13 - 5, 000 ng/mL. Sensitivity: 70.12 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●High Sensitivity — Optimized for low-abundance target detection. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Sensibilité	70.12 ng/mL
Plage	78.13 - 5, 000 ng/mL
Numéro d'accès	P04626
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	80-120%
Expédition	2-8 ℃
Stabilité et stockage	When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃.
Spécifications	Trastuzumab
Noms alternatifs	timigutuzumab, 4D5-8, 4D5V8, Herceptin, rhuMab HER2, 180288-69-1
Contexte	Receptor tyrosine-protein kinase erbB-2 (Trastuzumab) is a ~137 kDa protein. Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane.
Note	For Research Use Only.